https://www.marketscreener.com/quote/stock/ACTINIUM-PHARMACEUTICALS--16113719/news/Actinium-Highlights-Improved-Survival-with-Iomab-B-in-TP53-Positive-Relapsed-Refractory-Acute-Myeloi-46029495/?utm_source=telegram&utm_medium=social&utm_campaign=share